Enteric Disease Testing Market Size, Share, Growth Opportunities, Top Manufacturers, Trends, Key Segments, and Forecast to 2026

June 20 22:06 2024
Enteric Disease Testing Market Size, Share, Growth Opportunities, Top Manufacturers, Trends, Key Segments, and Forecast to 2026
Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region – Global Forecast to 2026

The global enteric disease testing market is estimated to be USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The growth in the enteric disease testing market is attributed to the enforcement of stringent food safety regulations and effective monitoring of the same by the regulatory authority, an increasing level of consumer awareness of food safety, and the availability of rapid technology with a low turnaround time. Lack of infrastructural facilities, high cost of replacement parts, and lack of harmonization act as major restraints for the enteric disease testing market.

Enteric Disease Testing Market

Enteric Disease Testing Market Drivers

1. Increasing Prevalence of Enteric Diseases: The global burden of enteric diseases, caused by pathogens like bacteria, viruses, and parasites, drives the demand for effective diagnostic solutions. Poor sanitation and hygiene, particularly in developing regions, contribute significantly to the prevalence of these diseases.

2. Growing Concerns About Food Safety: Consumers are becoming increasingly concerned about the safety of their food. Foodborne illnesses, which can be caused by contaminated food or water, are a major public health problem. Enteric disease testing plays a vital role in ensuring food safety by helping to identify and prevent the spread of foodborne pathogens. As concerns about food safety continue to rise, the demand for enteric disease testing is expected to grow.

3. Advancements in Diagnostic Technologies: The development of new and improved diagnostic technologies is another major driver of the enteric disease testing market. Rapid tests, which can provide results in a matter of minutes, are becoming increasingly popular. These tests are particularly useful in settings where quick diagnosis is essential, such as in hospitals and emergency departments. Additionally, molecular diagnostic tests, which can identify specific pathogens, are becoming more affordable and accessible, which is leading to their increased use in enteric disease testing.

4. Increasing Healthcare Expenditure and Awareness: Rising healthcare expenditure around the world is also contributing to the growth of the enteric disease testing market. As more money is allocated to healthcare, there is a greater investment in diagnostic testing. Additionally, growing public awareness about enteric diseases is leading to an increased demand for testing. People are becoming more proactive about their health and are more likely to seek testing if they experience symptoms of an enteric disease.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313

The meat, poultry and seafood food sub-segment is estimated to account for the largest market share in the by food end use segment of enteric disease testing market over the forecast period.

The global consumption of meat and processed meat products is highly rising. Further, with expanding globalization, food products are traded, which provides scope for various processes ranging from packaging, handling, storing and transportation, leading to food infestation. All these factors lead to an increased chance of contamination of the food, due to which the meat and seafood products are estimated to account for the highest market share in the market.

The rising health awareness among consumers in the North American region and presence of key players is projected to account for the largest market size during the forecast period.

The high level of awareness about healthy foods and nutrition is projected to drive the market growth for enteric disease testing market in North American region. Furthermore, the US and Canada combined have a high concentration of market players after Europe and are also high on technology adoption.

Top Companies in the Enteric Disease Testing Market

The enteric disease testing market is dominated by few globally established players such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia) and TÜV SÜD (Germany). These players have adopted growth strategies such as acquisitions, new product launches, and agreements to strengthen their presence in the global market.

SGS SA is engaged in the inspection, verification, testing, certification, and quality assurance services. The company has nine business segments—consumer & retail; agriculture food & life; oil, gas & chemical; minerals; industrial; government & institution; transportation; certification & business enhancement; and environmental health & safety. It offers enteric disease testing through its agriculture food & life segment. The company operates through a network of more than 2,400 offices and laboratories across Europe, the Middle East, the Americas, Africa, and the Asia Pacific. The company focuses on acquisitions and expansions as its key development strategy to maintain its market leader position and to strengthen its business in different segments. On June 2021, SGS announced the official opening of Its new food testing laboratory in Papua New Guinea, which would offer internationally recognized quality food testing manufacturing, hospitality, and retail market segments. There are many emerging opportunities, which are creating more competitors to the company such as, Eurofins (Luxembourg), Intertek (UK), and Bureau Veritas (France), among others.

Eurofins is an international group of laboratories that provide testing and support services to the pharmaceutical, food, environmental, agricultural, and consumer products industries and governments. The company capitalizes on a portfolio of 150,000 reliable analytical methods that enable it to offer services that characterize the safety, identity, purity, composition, authenticity, and origin of products & biological substances. It offers testing services through the following 13 divisions—food & feed testing, biopharma services, agroscience services, agro testing, clinical diagnostics, cosmetics testing, consumer product testing, forensic services, environmental testing, genomic services, medical devices, Eurofins technologies, and REACH services. It offers enteric disease testing services under its food & feed testing division.

Eurofins Scientific operates through 800 laboratories in 50 countries, and with such a strong global presence, the company can launch customized solutions for their customers and hence the company is identified as a strong player in the enteric disease testing market. The company’s business expansion continues to expand in North America and Europe, along with the focus on expanding and optimizing its laboratory network in the Asia Pacific region. The acquisition of Covance Food Solutions (US) in 2018 allowed the company to strengthen its geographic presence in the North American market.

Key Questions Addressed by the Enteric Disease Testing Market Report:

What is the enteric disease testing?

key factor affect the enteric disease testing market?

What is the reason for increase in enteric diseases?

Who are some of the key players operating in the enteric disease testing market?

What kind of stakeholders would be interested in this market?

Which regions suffer more with enteric diseases in the world?

What are the key market trends in the enteric disease testing market?

Book a meeting with our experts to discuss your business needs: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139763313

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/enteric-disease-testing-market-139763313.html